Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
7
currently held
Exits tracked
1
hand-checked
Sectors covered
3
across the portfolio
Countries covered
1
from every market
Latest activity
Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capitalCaledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week agoCapital Event · capital-cancellation-shares · Capital structure change
capital
Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks agoCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminLauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month agoBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin8 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
LAVA Therapeutics Ysios BioFund III | Ysios Capital Partners | 2020 | 1yr | Exited 2021 | – | – | |||
Kynexis2 periods Sunstone Life Science Ventures V | Sunstone Life Science Ventures | 2023 | 3yr | Active | – | – | |||
Northsea Therapeutics2 periods Ysios BioFund III | Ysios Capital Partners | 2017 | 9yr | Active | – | – | |||
Act Europe VI (BE VI) | Bridgepoint | 2021 | 5yr | Active | – | – | |||
Tagworks Pharmaceuticals Ysios BioFund III | Ysios Capital Partners | 2023 | 3yr | Active | – | – | |||
VarmX2 periods Ysios BioFund III | Ysios Capital Partners | 2020 | 6yr | Active | – | – | |||
De Hooge Waerder Abénex VI | Abénex | 2026 | 0yr | Active | – | – | |||
Trustmoore IK Small Cap IV | IK Partners | 2026 | 0yr | Active | – | – |
LAVA Therapeutics
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2020
Hold
1yr
Exit
2021
Kynexis
Sunstone Life Science Ventures V
NL
Sector
Biotech
InvestorSunstone Life Science Ventures
Entry
2023
Hold
3yr
Owners
2
Northsea Therapeutics
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2017
Hold
9yr
Owners
2
Act
Europe VI (BE VI)
NL
Sector
Business Services
InvestorBridgepoint
Entry
2021
Hold
5yr
Tagworks Pharmaceuticals
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2023
Hold
3yr
VarmX
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2020
Hold
6yr
Owners
2
De Hooge Waerder
Abénex VI
NL
Sector
Business Services
InvestorAbénex
Entry
2026
Hold
0yr
Trustmoore
IK Small Cap IV
NL
Sector
Financials
InvestorIK Partners
Entry
2026
Hold
0yr